Simon N. Pimstone, Director at Xenon Pharmaceuticals Inc. (XENE), sold 35,114 shares at $31.33 ($1.1M) on 2021-11-15, disclosed to the SEC on 2021-11-16.
Open-market sale of $1.1M XENE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.33 | 17,557 | $550K | 50.0% |
| 2 | $31.33 | 17,557 | $550K | 50.0% |
| Total | $31.33 avg | 35,114 | $1.1M | 100% |
| Filing → |
| XENE | SELL | 2022-08-16 | $10.9M | — | Filing → |
| XENE | SELL | 2022-03-08 | $2.2M | — | Filing → |
| XENE | SELL | 2022-03-08 | $77K | — | Filing → |